| Previous Close | 1.3500 |
| Open | 1.4900 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.4900 - 1.5000 |
| 52 Week Range | 1.0500 - 2.2500 |
| Volume | 500 |
| Avg. Volume | 10,469 |
| Market Cap | 19.32M |
| Beta (5Y Monthly) | 1.82 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0660 |
| Earnings Date | Feb 12, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its second quarter fiscal year ended December 31, 2019.
Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") today announced that it has scheduled a conference call to discuss second quarter of fiscal 2020 financial results on Thursday, February 13, 2020 at 5:00pm ET.
Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Jonathan Everett as the Company's new Vice President of Engineering.
Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the promotion of Daniel Habhegger to Chief Financial Officer of the Company. Mr. Habhegger initially joined Precision Optics in September 2019 as Director of Finance.
Conference Call Scheduled for today, November 14, 2019 at 5:00pm ET GARDNER, Mass. , Nov. 14, 2019 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer ...
GARDNER, Mass. , Nov. 7, 2019 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") today announced that it has scheduled a conference call to discuss first quarter ...
Conference Call Scheduled for today, September 26, 2019 at 5:00pm ET GARDNER, Mass. , Sept. 26, 2019 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer ...
GARDNER, Mass. , Sept. 23, 2019 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") today announced that it has scheduled a conference call to discuss fourth quarter ...
Conference Call Scheduled for today, August 15, 2019 at 5:00pm ET GARDNER, Mass. , Aug. 15, 2019 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of ...
GARDNER, Mass. , Aug.12, 2019 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") today announced that it has scheduled a conference call to discuss preliminary fourth ...
For more than 20 years, Lytham Partners has been one of the country's leading investor relations firms, having created one of the industry's largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with many of the industry's most respected institutional investors, Lytham Partners has spent the past two decades creating an integrated platform that allows its clients far reaching exposure to investors in a consistent and in-depth format.
Strategic acquisition expands Precision Optics’ product offering and presence within the U.S. defense sector Company closes $950,000 equity raise tied to acquisition GARDNER,.
Precision Optics Corporation, Inc. (PEYE) (the “Company”) announced today that Dr. Kenneth Schwartz passed away on June 13, 2019. Dr. Schwartz was a valued member of the Company’s Board of Directors since 2014. Joe Forkey, Company President and CEO, commented, “We were saddened to learn of the loss of Dr. Ken Schwartz.
GARDNER, Mass., May 15, 2019 -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced operating results on an unaudited basis for its fiscal year.
GARDNER, Mass., May 08, 2019 -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced that it intends to release its financial results for the fiscal.
Precision Optics Corporation, Inc. (PEYE) today announced that it has received a follow-on order totaling $2,216,000 from CardioFocus, Inc. for the manufacture of a cardiovascular endoscope to support the HeartLight Endoscopic Ablation System. The HeartLight System allows physicians to treat atrial fibrillation with a minimally invasive procedure that offers real-time imaging, precise laser energy delivery and full-color perspective. Precision Optics partnered with CardioFocus from design through prototyping, clinical trials, and production. Improving on early CardioFocus designs, Precision Optics was able to achieve a manufacturable and robust 500-micron diameter endoscope with a wide, 110-degree field of view for insertion into the balloon catheter, allowing the physician to precisely monitor and adjust the location of energy delivery.